FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称ATEZOLIZUMAB
异名/同义词0INE2SFD9E
AN ANTIBODY TO PROGRAMMED DEATH LIGAND 1 FOR CANCER THERAPY
ATEZOLIZUMAB
ATEZOLIZUMAB [INN]
ATEZOLIZUMAB [JAN]
ATEZOLIZUMAB [MI]
ATEZOLIZUMAB [PURPLE BOOK CDER]
ATEZOLIZUMAB [USAN]
ATEZOLIZUMAB [WHO-DD]
ATEZOLIZUMAB-TQJC
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD ANTIGEN CD274) (HUMAN MONOCLONAL MPDL3280A HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MPDL3280A .KAPPA.-CHAIN, DIMER
MPDL3280A
MPDL-3280A
RG7446
RG-7446
TECENTRIQ
TECENTRIQ HYBREZA COMPONENT ATEZOLIZUMAB
CAS登记号1380723-44-3
物质唯一标识(Unique Ingredient Identifier)52CMI0WC3Y
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System